28/10/25

Join the Life Sciences Seminar 2025 on Tuesday, 28 October, from 2:00 to 6:00 pm at the NautaDutilh Amsterdam office.

Key players in the life sciences industry will come together for an afternoon of insight and exchange, exploring the evolving regulatory and business landscape in biotech and pharma. Hosted by NautaDutilh, this seminar will spotlight challenges and opportunities across Europe and the USA.

We will kick off the event with Michael Labson (Co-chair of the global Life Sciences practice at Covington & Burling and Managing Partner of the firm’s Boston office) who will deliver a keynote on policy developments under the Trump administration affecting the biopharmaceutical sector. Key topics will include changes at the U.S. Food and Drug Administration (FDA); most favoured nation drug pricing proposals, and tariffs.

This keynote will be followed by a fireside chat with, among others, Dirk Kersten (Partner Forbion Growth), Sander van Deventer (CSO Vectory Therapeutics) and Wieteke Wouters (Program Director hollandbio). They will discuss the impact on European Biotech companies, the European regulatory landscape, and the availability of medicines, moderated by Ruud Smits (NautaDutilh).

Participants can join two of six expert-led round tables on the following topics:

IPO readiness
Fundraising trends and opportunities
Increasing regulatory hurdles for transactions in the life sciences sector
Data Regulations & Drug discovery: from data protection to data use and valorisation
AI and drug discovery and IP implication
IP licensing and research collaboration

Interested in joining the seminar? Please contact Tirza Martens via events.nl@nautadutilh.com.

door Idalia Dlugosz